title: [Chronic viral hepatitis due to the hepatitis C virus (HCV): treatment experience with lymphoblast interferon-alpha].
abstract: Ten patients affected with HCV-related chronic hepatitis received alpha lymphoblastoid-IFN, 3 mU i.m. TW, for 12 months. We obtained: 4 complete responses, 5 partial responses, 1 non-response (therapy stopped after 3 months). During the fourteen months follow-up, 4 patients (1 complete responder, 3 partial responders) relapsed.
authors.affiliation: Regione Calabria, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria.
authors.forename: G
authors.initials: G
authors.lastname: Foti
authors.forename: M
authors.initials: M
authors.lastname: De Cicco
authors.forename: A
authors.initials: A
authors.lastname: Masseo
authors.forename: C
authors.initials: C
authors.lastname: Mangano
authors.forename: A
authors.initials: A
authors.lastname: Tripodi
authors.forename: N
authors.initials: N
authors.lastname: Foti
mesh_terms: D000328:Adult; D002908:Chronic Disease; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006526:Hepatitis C / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D013997:Time Factors
chemical_list: D016898:Interferon-alpha